Company's Flagship Product, The Slinger Bag, Top Rated Among 2022 Tennis Products
NEW YORK , May 5, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today reported that, on March 30, 2022 , Slinger Bag Inc. ("Slinger Bag") filed a Form S-1/A with the Securities and Exchange Commission ("SEC") requesting that the company's shares of common stock be publicly listed on the Nasdaq Capital Market under the symbol "CNXA."
AIkido previously announced that it entered into an August 6, 2021 , securities purchase agreement with Slinger Bag, which is the maker of The Slinger Bag, an advanced tennis ball shooter with a wheeled-bag design.
In addition, in an April 29, 2022 , article published by Science Focus, The Slinger Bag is rated as one of "[t]he best tennis gadgets for true fans of the sport in 2022." The article describes "The Slinger Bag [as] a complete tennis ball shooter that can keep you training all over the court. With a minimum launch speed of 10 mph and a max speed of 45 mph, and an oscillator to keep the balls coming in random directions, it can provide a refreshingly varied training session. The wheeled-bag design helps to make it super easy to transport too." (https://www.sciencefocus.com/buyers-guides/best-tennis-gadgets/).
Anthony Hayes , CEO of AIkido, stated, "We congratulate Slinger Bag on filing its application for public listing of its common stock on the NASDAQ. We also congratulate the company for achieving inclusion of The Slinger Bag on a very short list of the best tennis gadgets of 2022. In addition to the company's requested public offering, we are optimistic this top rating for The Slinger Bag will bode well for the future of our investment in this outstanding company. We believe that Slinger Bag is another accretive investment for AIkido shareholders and the potential liquidity event here, will be a benefit to our Company."
AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology Company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics. The Company's platform consists of patented technology from leading universities and researchers, and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The University of Texas at Austin and University of Maryland at Baltimore . Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, prostate cancer. We are constantly seeking to grow our pipeline to treat unmet medical needs in oncology. The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus.
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the SEC, not limited to Risk Factors relating to its business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.
Hayden IR Brett Maas , Managing Partner Phone: (646) 536-7331 Email: brett@haydenir.com www.haydenir.com
AIkido Pharma Inc. Phone: 212-745-1373 Email: investorrelations@aikidopharma.com www.aikidopharma.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/aikido-reports-slinger-bag-incs-filing-for-nasdaq-public-listing-301540834.html
Homeowners beware. But don't panic, either.
KEY WORDS “I think we’re giving Powell too much praise. … The last two years are one of the biggest policy mistakes in the 110-year history of the Fed by staying so easy when everything was booming.
Yes, there's a lot of economic concerns, but this is a buying opportunity (and things aren't nearly as bad as they seem).
Workers questioned Google execs earlier this year after the company's 'Googlegeist' survey results came out.
Warren Buffett’s long-term investment strategy has proven to be successful through virtually all market conditions over the past several decades – recession, high inflation and deflation. If there’s one thing that’s made Buffett one of the most successful investors in history, it’s his commitment to his strategy. A countless number of new investment techniques and algorithms have come and gone over the years, but Buffett has maintained his relatively simple strategy of picking solid companies an
Dividends can be used to create passive income in an investment portfolio or grow wealth over the long term through reinvestment. Knowing how to live off dividends may be central to your retirement planning strategy if you want to avoid … Continue reading → The post How Much Do You Need to Live Off Dividends? appeared first on SmartAsset Blog.
Today, with the stock market in meltdown mode, it’s natural to look back at other times of financial woe. The market environment in the 1970s can be particularly instructive.
Institutional ownership of single-family homes has been a controversial topic over the past year. Investors purchased a record-high number of rental properties while many would-be homeowners were priced out of the market. The largest owner of this asset class in the U.S. is Invitation Homes Inc. (NYSE: INVH), a real estate investment trust (REIT) with a portfolio of about 83,000 single-family rental homes as of the end of the first quarter this year. The company’s portfolio is mainly made up of
Goldman finally decided to stop fighting the Fed and no longer sees the index finishing the year at 4300.
(Bloomberg) -- An Idaho man who worked as an information technology professional admitted to making at least $3.5 million by illegally accessing the stock picks of the personal finance website Motley Fool before they were released.Most Read from BloombergBank of England Says Paper Banknotes Only Good for One More WeekLiz Truss’s Historic Gamble With the UK Economy Is Already UnravelingLeaked Study Shows Exxon, Partners Overspent by $138 BillionRisk Assets Crushed With Few Signs Drama Is Over: Ma
(Bloomberg) -- Russia’s wheat harvest could reach a historic 100 million tons, according to consultant SovEcon, with the commodity piling up at home as the nation struggles to export large volumes.Most Read from BloombergBank of England Says Paper Banknotes Only Good for One More WeekJapan to Restore Visa-Free Travel From Oct. 11 as Covid Pandemic Recedes South Korea President Caught on Hot Mic Insulting US CongressUnless Rents Rise, Housing Is Set Up for an Epic CrashA Great Copper Squeeze Is C
In this article, we discuss the 11 best commodity stocks to invest in. If you want to read about some more commodity stocks, go directly to 5 Best Commodity Stocks To Invest In. Macroeconomic concerns have been clouding the commodities market in the past few days after the Federal Reserve in the United States hiked […]
These are the dividend stocks in the Russell 1000 with the highest forward dividend yield for September.
The shipping company has developed a reputation as one of the best dividend stocks around
In this article, we will look at the 4 stocks billionaire Leon Cooperman is talking about right now. If you want to skip reading about Leon Cooperman, his investment career, and his stock-picking strategy, you can go directly to Billionaire Leon Cooperman is Talking About These 2 Stocks. Leon Cooperman’s Investment Career Leon Cooperman is […]
The hedge fund legend has spoken. Pay attention.
Investing for the long term is the best way to grow your wealth. And these three stocks can help you do it.
AT&T (NYSE: T) and IBM (NYSE: IBM) both underwent dramatic transformations over the past year. AT&T divested DirecTV, merged WarnerMedia with Discovery to create Warner Bros. Discovery (NASDAQ: WBD) , and sold many of its non-core assets to prioritize the growth of its core telecom business.
Federal Reserve officials have a busy week of speeches ahead. Investors are desperate for more information on the future of rates.
Trending social-media hashtags aside, the U.S. stock market hasn't crashed --- but a volatile bear market is making for queasy investors.